Annual Revenue
$18.16 M
+$2.62 M+16.83%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual revenue is $18.16 million, with the most recent change of +$2.62 million (+16.83%) on April 30, 2024.
- During the last 3 years, IPA annual revenue has risen by +$4.47 million (+32.64%).
- IPA annual revenue is now at all-time high.
Performance
IPA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$4.49 M
+$643.40 K+16.74%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly revenue is $4.49 million, with the most recent change of +$643.40 thousand (+16.74%) on October 31, 2024.
- Over the past year, IPA quarterly revenue has increased by +$643.40 thousand (+16.74%).
- IPA quarterly revenue is now -5.73% below its all-time high of $4.76 million, reached on April 30, 2024.
Performance
IPA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$17.69 M
-$41.60 K-0.23%
October 31, 2024
Summary
- As of February 8, 2025, IPA TTM revenue is $17.69 million, with the most recent change of -$41.60 thousand (-0.23%) on October 31, 2024.
- Over the past year, IPA TTM revenue has dropped by -$41.60 thousand (-0.23%).
- IPA TTM revenue is now -2.53% below its all-time high of $18.15 million, reached on April 30, 2024.
Performance
IPA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
IPA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.8% | +16.7% | -0.2% |
| 3 y3 years | +32.6% | +16.7% | -0.2% |
| 5 y5 years | +119.0% | +16.7% | -0.2% |
IPA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.6% | -5.7% | +23.2% | -2.5% | +16.7% |
| 5 y | 5-year | at high | +119.0% | -5.7% | +63.0% | -2.5% | +86.6% |
| alltime | all time | at high | -100.0% | -5.7% | +3744.0% | -2.5% | -100.0% |
ImmunoPrecise Antibodies Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | $4.49 M(+16.7%) | $17.69 M(-0.2%) |
| Jul 2024 | - | $3.84 M(-19.3%) | $17.73 M(-2.3%) |
| Apr 2024 | $18.16 M(+16.8%) | $4.76 M(+3.3%) | $18.15 M(+3.5%) |
| Jan 2024 | - | $4.61 M(+1.7%) | $17.54 M(+4.6%) |
| Oct 2023 | - | $4.53 M(+6.3%) | $16.77 M(+3.9%) |
| Jul 2023 | - | $4.26 M(+2.8%) | $16.13 M(+4.0%) |
| Apr 2023 | $15.54 M(+0.7%) | $4.14 M(+8.1%) | $15.51 M(+0.1%) |
| Jan 2023 | - | $3.83 M(-1.6%) | $15.50 M(+0.2%) |
| Oct 2022 | - | $3.89 M(+7.0%) | $15.47 M(+0.9%) |
| Jul 2022 | - | $3.64 M(-11.9%) | $15.33 M(-0.6%) |
| Apr 2022 | $15.43 M(+12.7%) | $4.13 M(+8.8%) | $15.42 M(+1.7%) |
| Jan 2022 | - | $3.80 M(+1.2%) | $15.16 M(+2.0%) |
| Oct 2021 | - | $3.75 M(+0.6%) | $14.87 M(+1.1%) |
| Jul 2021 | - | $3.73 M(-3.6%) | $14.71 M(+7.1%) |
| Apr 2021 | $13.69 M(+30.0%) | $3.87 M(+10.4%) | $13.73 M(+6.6%) |
| Jan 2021 | - | $3.51 M(-2.4%) | $12.87 M(+3.6%) |
| Oct 2020 | - | $3.60 M(+30.6%) | $12.43 M(+10.8%) |
| Jul 2020 | - | $2.75 M(-8.8%) | $11.22 M(+6.7%) |
| Apr 2020 | $10.53 M(+27.0%) | $3.02 M(-1.6%) | $10.52 M(+10.9%) |
| Jan 2020 | - | $3.07 M(+28.3%) | $9.48 M(+12.3%) |
| Oct 2019 | - | $2.39 M(+16.8%) | $8.44 M(+3.7%) |
| Jul 2019 | - | $2.04 M(+3.1%) | $8.14 M(-1.9%) |
| Apr 2019 | $8.29 M(+94.4%) | $1.98 M(-2.0%) | $8.29 M(+7.3%) |
| Jan 2019 | - | $2.02 M(-2.9%) | $7.73 M(+9.3%) |
| Oct 2018 | - | $2.08 M(-5.4%) | $7.07 M(+17.1%) |
| Jul 2018 | - | $2.20 M(+54.9%) | $6.04 M(+41.0%) |
| Apr 2018 | $4.26 M(+113.6%) | $1.42 M(+4.4%) | $4.28 M(+29.5%) |
| Jan 2018 | - | $1.36 M(+29.4%) | $3.31 M(+42.0%) |
| Oct 2017 | - | $1.05 M(+135.4%) | $2.33 M(+82.4%) |
| Jul 2017 | - | $447.10 K(+0.0%) | $1.28 M(+53.9%) |
| Apr 2017 | $2.00 M | $446.90 K(+16.7%) | $829.90 K(+116.7%) |
| Jan 2017 | - | $383.00 K(-411.1%) | $383.00 K(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2008 | - | -$123.10 K(-197.4%) | $3300.00(-97.4%) |
| Sep 2008 | - | $126.40 K(+487.9%) | $126.40 K(+487.9%) |
| Sep 2007 | - | $21.50 K(+377.8%) | $21.50 K(+55.8%) |
| Jun 2006 | - | $4500.00(-51.6%) | $13.80 K(+9.5%) |
| Sep 2005 | - | $9300.00(+181.8%) | $12.60 K(+21.2%) |
| Jun 2005 | - | $3300.00(-53.5%) | $10.40 K(+3.0%) |
| Sep 2004 | - | $7100.00(+136.7%) | $10.10 K(+236.7%) |
| Jun 2004 | - | $3000.00(+2900.0%) | $3000.00(+900.0%) |
| Dec 2001 | $200.00(0.0%) | - | - |
| Jun 2001 | - | $100.00(>+9900.0%) | $300.00(+50.0%) |
| Mar 2001 | - | $0.00(-100.0%) | $200.00(0.0%) |
| Dec 2000 | $200.00(-96.1%) | - | - |
| Dec 2000 | - | $200.00(>+9900.0%) | $200.00(-96.2%) |
| Sep 2000 | - | $0.00(0.0%) | $5200.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) | $5200.00(0.0%) |
| Mar 2000 | - | $0.00(-100.0%) | $5200.00(0.0%) |
| Dec 1999 | $5100.00(-85.7%) | - | - |
| Dec 1999 | - | $5200.00(>+9900.0%) | $5200.00(-84.8%) |
| Sep 1999 | - | $0.00(0.0%) | $34.20 K(0.0%) |
| Jun 1999 | - | $0.00(0.0%) | $34.20 K(0.0%) |
| Mar 1999 | - | $0.00(-100.0%) | $34.20 K(0.0%) |
| Dec 1998 | $35.60 K(>+9900.0%) | - | - |
| Dec 1998 | - | $34.20 K(>+9900.0%) | $34.20 K(>+9900.0%) |
| Sep 1998 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 1998 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1998 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1997 | $0.00(-100.0%) | - | - |
| Dec 1997 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 1997 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 1997 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1997 | - | $0.00 | $0.00 |
| Dec 1996 | $4800.00 | - | - |
FAQ
- What is ImmunoPrecise Antibodies annual revenue?
- What is the all time high annual revenue for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual revenue year-on-year change?
- What is ImmunoPrecise Antibodies quarterly revenue?
- What is the all time high quarterly revenue for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly revenue year-on-year change?
- What is ImmunoPrecise Antibodies TTM revenue?
- What is the all time high TTM revenue for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies TTM revenue year-on-year change?
What is ImmunoPrecise Antibodies annual revenue?
The current annual revenue of IPA is $18.16 M
What is the all time high annual revenue for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual revenue is $18.16 M
What is ImmunoPrecise Antibodies annual revenue year-on-year change?
Over the past year, IPA annual revenue has changed by +$2.62 M (+16.83%)
What is ImmunoPrecise Antibodies quarterly revenue?
The current quarterly revenue of IPA is $4.49 M
What is the all time high quarterly revenue for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly revenue is $4.76 M
What is ImmunoPrecise Antibodies quarterly revenue year-on-year change?
Over the past year, IPA quarterly revenue has changed by +$643.40 K (+16.74%)
What is ImmunoPrecise Antibodies TTM revenue?
The current TTM revenue of IPA is $17.69 M
What is the all time high TTM revenue for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high TTM revenue is $18.15 M
What is ImmunoPrecise Antibodies TTM revenue year-on-year change?
Over the past year, IPA TTM revenue has changed by -$41.60 K (-0.23%)